Frank O, Klicpera M, Kolarz G, Scherak O
Wien Klin Wochenschr. 1975 Jun 27;87(13):427.
Thirty patients with classical or definite rheumatoid arthritis were treated over a 4-week period with diftalone, a new non-steroidal antirheumatic drug. The daily dosage ranged from 500 to 1000 mg. A good objective response was achieved in 69% of the patients. Diftalone was well tolerated. Side effects were noted in 11.8% of patients on 500 mg diftalone daily and in 18.8% of cases treated with the highest dosage (1000 mg daily). The optimum daily dosage appears to be 750 mg.
30例典型或确诊类风湿性关节炎患者在4周内接受了新型非甾体类抗风湿药二氟尼柳治疗。日剂量为500至1000毫克。69%的患者获得了良好的客观反应。二氟尼柳耐受性良好。每日服用500毫克二氟尼柳的患者中11.8%出现副作用,最高剂量(每日1000毫克)治疗的病例中18.8%出现副作用。最佳日剂量似乎为750毫克。